ASCO Daily News
By American Society of Clinical Oncology (ASCO)
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Category: Medicine
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 39
Reviews: 0
Episodes: 100
Description
The ASCO Daily News Podcast features oncologists discussing the latest research and therapies in their areas of expertise.
| Episode | Date |
|---|---|
|
ASCO25 Preview: Key Research Accelerating Cancer Care
|
May 22, 2025 |
|
Optimizing Oncology Clinical Pathways at the Point of Care
|
Apr 17, 2025 |
|
Personalizing Lung Cancer Management With ctDNA: Where We Are and Where We Are Headed
|
Apr 03, 2025 |
|
The Evolving Role of Precision Surgery in Gynecologic Cancers
|
Mar 13, 2025 |
|
Emerging Therapies in Acute Myeloid Leukemia
|
Mar 06, 2025 |
|
Practice-Informing Research Across GU Oncology: Highlights From GU25
|
Feb 27, 2025 |
|
Therapeutic Advances Across GI Cancers: Highlights From GI25
|
Feb 06, 2025 |
|
Advances in Adjuvant Therapy for High-Risk Early Breast Cancer With Germline Mutations
|
Jan 30, 2025 |
|
How to Advance Cancer Care for Native Americans
|
Jan 09, 2025 |
|
What Challenges Will Oncologists Face in 2025?
|
Dec 05, 2024 |
|
A New Standard of Care for Cervical Cancer: Assessing the KEYNOTE-A18 Study
|
Nov 21, 2024 |
|
Advances in Immunotherapy for Melanoma and Beyond
|
Oct 31, 2024 |
|
Personalizing Locoregional Treatment for Breast Cancer
|
Oct 17, 2024 |
|
How Are Cancer Centers Navigating IV Fluid Shortages and the Devastation of Hurricane Season?
|
Oct 09, 2024 |
|
Key Takeaways From the 2024 ASCO Quality Care Symposium
|
Oct 03, 2024 |
|
Key Takeaways From 2024 ASCO Breakthrough
|
Aug 22, 2024 |
|
How AI Can Improve Patient Identification and Recruitment for Clinical Trials
|
Aug 15, 2024 |
|
DESTINY-Breast06 and A-BRAVE: Advances in Breast Cancer Research
|
Aug 08, 2024 |
|
The Risks and Benefits of Taking a Break From Cancer Treatment
|
Aug 01, 2024 |
|
How to Enhance Early-Stage Breast Cancer Survivorship
|
Jul 25, 2024 |
|
Putting Patients First: Common Sense in Cancer Care
|
Jul 18, 2024 |
|
An Era of Promise for Cancer Vaccines
|
Jul 11, 2024 |
|
GU Oncology Highlights From ASCO24
|
Jun 27, 2024 |
|
Top ASCO24 Abstracts That Could Revolutionize Oncology
|
Jun 26, 2024 |
|
Enhancing Treatment Efficacy in Multiple Myeloma at ASCO24
|
Jun 24, 2024 |
|
ASCO24: Transforming the Lung Cancer Treatment Landscape
|
Jun 21, 2024 |
|
ESOPEC and Other Key GI Studies at ASCO24
|
Jun 20, 2024 |
|
Immunotherapy at ASCO24: NADINA and Other Key Studies
|
Jun 19, 2024 |
|
Day 4: Top Takeaways From ASCO24
|
Jun 03, 2024 |
|
Day 3: Top Takeaways From ASCO24
|
Jun 02, 2024 |
|
Day 2: Top Takeaways From ASCO24
|
Jun 01, 2024 |
|
Day 1: Top Takeaways From ASCO24
|
May 31, 2024 |
|
Exploring CAR T Cells in GI Cancers at ASCO24
|
May 25, 2024 |
|
Key Abstracts in GU Cancers at ASCO24
|
May 25, 2024 |
|
Novel Approaches in Hematologic Malignancies at ASCO24
|
May 24, 2024 |
|
ASCO24: The Future of Personalized Immunotherapy
|
May 24, 2024 |
|
Spotlight on Breast Cancer at ASCO24
|
May 23, 2024 |
|
ASCO24: The Era of the ADCs in NSCLC
|
May 23, 2024 |
|
Optimizing Novel Therapies and Surgery in Early-Stage NSCLC
|
Apr 25, 2024 |
|
A Revolution in Immunotherapy for Cervical and Endometrial Cancers
|
Apr 18, 2024 |
|
How ctDNA Is Advancing Care for Patients With GI Cancers
|
Apr 04, 2024 |
|
New Machine Learning Framework Uses EHR Data to Assess ICI Effectiveness, Toxicity
|
Mar 21, 2024 |
|
Innovations in CAR T-Cell Therapy for Multiple Myeloma
|
Mar 07, 2024 |
|
ADCs in Breast Cancer: Sequencing, Resistance, and Managing Toxicity
|
Feb 15, 2024 |
|
Advances in Precision Oncology for GI Cancers at GI24
|
Feb 08, 2024 |
|
Key Advances in Prostate, Kidney, and Bladder Cancers at GU24
|
Feb 06, 2024 |
|
What’s New in Prostate Cancer, RCC, and mUC at GU24
|
Jan 22, 2024 |
|
Celebrating 20 Years of Evolution in GU Oncology
|
Dec 14, 2023 |
|
What the FDA CAR T-Cell Therapy Investigation Means for Oncologists
|
Dec 07, 2023 |
|
Managing the Complexities of Oncology Practice in 2024
|
Dec 07, 2023 |
|
Solutions and Key Research to Advance High-Quality Cancer Care
|
Nov 09, 2023 |
|
How to Implement Universal Germline Testing for CRC
|
Nov 02, 2023 |
|
Changing the Gut Microbiome to Improve the Efficacy of Immunotherapy
|
Oct 12, 2023 |
|
Navigating the Complexities of Next-Generation Endocrine Therapy in HR+ Breast Cancer
|
Sep 28, 2023 |
|
ASCO Breakthrough: Scientific Innovations and Emerging Technologies in Cancer Care
|
Aug 17, 2023 |
|
How Oncologists Are Confronting the Cancer Drug Shortage
|
Aug 10, 2023 |
|
AI Will Allow Doctors to Reclaim Time With Patients
|
Aug 03, 2023 |
|
Managing the Side Effects of Endocrine Therapy for Breast Cancer
|
Jul 27, 2023 |
|
The Emergence of Triplet Therapies in ccRCC in the Frontline Setting
|
Jul 13, 2023 |
|
Novel Therapies in GI Oncology at ASCO23
|
Jun 28, 2023 |
|
THOR, CONTACT-03, and Other Advances in GU Cancers at ASCO23
|
Jun 27, 2023 |
|
Spotlight on Immunotherapy at ASCO23
|
Jun 26, 2023 |
|
Highlights in Hematologic Malignancies at ASCO23
|
Jun 23, 2023 |
|
ADAURA, KEYNOTE-671, and Other Key Advances in Lung Cancer at ASCO23
|
Jun 22, 2023 |
|
SONIA, NATALEE, and Other Advances in Breast Cancer at ASCO23
|
Jun 21, 2023 |
|
Addressing the Impact of Prior Authorization on Access to Cancer Treatment
|
Jun 08, 2023 |
|
ASCO23: RELATIVITY-047, CheckMate-038, and Other Advances in Immunotherapy
|
May 25, 2023 |
|
ASCO23: COMMANDS, CAPTIVATE, and Key Studies in Hematologic Malignancies
|
May 25, 2023 |
|
ASCO23: Novel Approaches in RCC, mUC, and Prostate Cancer
|
May 25, 2023 |
|
ASCO23: CodeBreak-101, NAPOLI-3, and Other Advances in GI Cancers
|
May 25, 2023 |
|
ASCO23: Novel Therapies in Lung Cancer
|
May 25, 2023 |
|
ASCO23: PALMIRA, LEONARDA-1, and Other Advances in Breast Cancer
|
May 25, 2023 |
|
ASCO23: Key Abstracts from Precision Oncology to Cancer Disparities
|
May 25, 2023 |
|
S2302 Pragmatica-Lung and the Promise of Streamlined Clinical Trials
|
Apr 13, 2023 |
|
Advances in Neoadjuvant IO in MSI-H/dMMR Colorectal Cancer
|
Mar 16, 2023 |
|
Key Abstracts in Prostate, Bladder, and Kidney Cancers at GU23
|
Mar 02, 2023 |
|
ARASENS, TRITON3, and Other Key Advances at GU23
|
Feb 13, 2023 |
|
SWOG 1815, PARADIGM, and Other Advances at GI23
|
Feb 02, 2023 |
|
Fertility Concerns, Family Planning, and Career Decisions Among Female Oncologists
|
Jan 05, 2023 |
|
What Challenges Will Oncologists Face in 2023?
|
Dec 08, 2022 |
|
Developing the Next Generation of Prostate Cancer Researchers
|
Nov 15, 2022 |
|
Novel Therapies Targeting KRAS in Lung Cancer & RAS-Altered Tumors
|
Nov 03, 2022 |
|
Advancing Equity and Quality Cancer Care at #ASCOQLTY22
|
Oct 14, 2022 |
|
The Impact of Hurricane Ian on Cancer Care
|
Oct 12, 2022 |
|
How Primary Tumor Sidedness Impacts Treatment and Other Advances in Colorectal Cancer
|
Sep 15, 2022 |
|
Update from Poland: Cancer Care for Ukrainian Refugees
|
Aug 11, 2022 |
|
A Novel Approach to Address Financial Toxicity
|
Jul 28, 2022 |
|
Hidden Gems From ASCO22: Abstracts on EDI, Health Care Economics, and More
|
Jul 14, 2022 |
|
Novel Therapies in GI Oncology at ASCO22
|
Jun 27, 2022 |
|
Spotlight on Immunotherapy at ASCO22
|
Jun 23, 2022 |
|
Advances in Hematologic Malignancies at ASCO22
|
Jun 22, 2022 |
|
DESTINY-Breast04 and Other Key Breast Cancer Studies at ASCO22
|
Jun 21, 2022 |
|
Advances in Genitourinary Cancers at ASCO22
|
Jun 18, 2022 |
|
Advances in Lung Cancer at ASCO22
|
Jun 17, 2022 |
|
ASCO22 Scientific Program: Dynamic Sessions and Advances Across the Spectrum of Malignancies
|
Jun 01, 2022 |
|
ASCO22: Key Posters on Advances in Immunotherapy
|
May 27, 2022 |
|
ASCO22: Key Advances in Hematologic Malignancies
|
May 27, 2022 |
|
ASCO22: Novel Therapies in Breast Cancer
|
May 27, 2022 |
|
ASCO22: Key Posters on Advances in GI Oncology
|
May 26, 2022 |
|
ASCO22: Novel Therapies in Lung Cancer
|
May 26, 2022 |